Body dysmorphic disorder (BDD) is a severe psychiatric disorder, where the patient is obsessed with its own appearance. Recent study of PhD Candidates Daan Neuteboom and Maaike van Paridon of Amsterdam UMC, shows positive effects in the first few BDD patients treated with a relatively new form of brain stimulation. This study was recently published in the journal Brain Stimulation.

BDD is characterized by the obsessive idea that one or more body parts are repulsive, while these flaws are usually unnoticeable by others. These obsessive thoughts are often accompanied by depressive symptoms. Currently, the treatment options for BDD are antidepressants and cognitive behavioral therapy. Since many patients show insufficient response to these options, new treatment modalities are urgently needed.

Non-invasive brain stimulation

Under supervision of Psychiatrist Karel Scheepstra and Nienke Vulink, Neuteboom and van Paridon treated five BDD patients with a form of brain stimulation which does not require surgery or implantation of electrodes, called repetitive Transcranial Magnetic Stimulation (rTMS). This treatment is already proven effective in patients who suffer from depressive symptoms but has never been assessed in patients with BDD. In this study, rTMS was applied according to a depression protocol to find out if the treatment could potentially alleviate both BDD and depressive symptoms.

Repetitive Transcranial Magnetic Stimulation (rTMS) of the left dorsolateral prefrontal cortex (dlPFC) in five patients with BDD and Major Depressive Disorder (MDD).
Repetitive Transcranial Magnetic Stimulation (rTMS) of the left dorsolateral prefrontal cortex (dlPFC) in five patients with BDD and Major Depressive Disorder (MDD).

Positive effects shown in five patients

In this first study on rTMS in BDD patients, the effects are positive. All five patients had significant reduction of depressive symptoms and three out of five patients had a significant reduction of their BDD symptoms. Furthermore, the rTMS was tolerated well and no severe side-effects were seen. As a result of the positive effects in this small number of patients, a larger sham controlled study is currently being performed at Amsterdam UMC, location AMC, to study the efficacy of rTMS in BDD on a larger scale.